Stock A007370 JIN YANG PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

All News Jin Yang Pharmaceutical Co., Ltd.

Equities

A007370

KR7007370000

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-07-04 pm EDT 		5-day change 1st Jan Change
5,330 KRW +1.14% Intraday chart for Jin Yang Pharmaceutical Co., Ltd. -3.44% -13.89%
Apr. 09 Jin Yang Pharmaceutical Co., Ltd.'s Equity Buyback Plan Extended till April 9, 2025. CI
2023 Jin Yang Pharmaceutical Co. Ltd.'s Equity Buyback Plan Extended till December 22, 2024. CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Jin Yang Pharmaceutical Co., Ltd.'s Equity Buyback Plan Extended till April 9, 2025.
CI
Jin Yang Pharmaceutical Co. Ltd.'s Equity Buyback Plan Extended till December 22, 2024.
CI
Jin Yang Pharmaceutical Co., Ltd.'s Equity Buyback Plan Extended till November 18, 2024.
CI
Jin Yang Pharmaceutical Co. Ltd.'s Equity Buyback Plan Extended till December 22, 2023.
CI
Jin Yang Pharmaceutical Co., Ltd.'s Equity Buyback Plan Extended till November 18, 2023.
CI
Tranche Update on Jin Yang Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on August 24, 2022.
CI
Jin Yang Pharmaceutical Co., Ltd.'s Equity Buyback announced on August 24, 2022, has closed with 158,983 shares, representing 1.42% for KRW 1,024.7 million.
CI
Jin Yang Pharmaceutical Co., Ltd. announces an Equity Buyback for 158,983 shares.
CI
Tranche Update on Jin Yang Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on August 19, 2022.
CI
Jin Yang Pharmaceutical Co., Ltd. authorizes a Buyback Plan.
CI
Jin Yang Pharmaceutical Co., Ltd.'s Equity Buyback announced on August 19, 2022, has closed with 161,813 shares, representing 1.45% for KRW 1,036.80 million.
CI
Jin Yang Pharmaceutical Co., Ltd. announces an Equity Buyback for 161,813 shares.
CI
Tranche Update on Jin Yang Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on August 12, 2022.
CI
Jin Yang Pharmaceutical Co., Ltd. authorizes a Buyback Plan.
CI
Jin Yang Pharmaceutical Co., Ltd.'s Equity Buyback announced on August 12, 2022, has closed with 81,038 shares, representing 0.72% for KRW 512.62 million.
CI
Jin Yang Pharmaceutical Co., Ltd. announces an Equity Buyback for 81,038 shares.
CI
Jin Yang Pharmaceutical Co., Ltd. authorizes a Buyback Plan.
CI
Jin Yang Pharmaceutical Co. Ltd.'s Equity Buyback announced on October 10, 2006 has expired.
CI
Jin Yang Pharmaceutical Co., Ltd. announced that it has received KRW 16 billion in funding from Shinhan Investment Corp., Investment Arm, Mirae Asset Daewoo Co., Ltd., Investment Arm, HisStory Investment Management, Investment arm and other investors
CI
Jin Yang Pharmaceutical Co., Ltd. announced that it expects to receive KRW 16 billion in funding from Shinhan Investment Corp., Investment Arm, Mirae Asset Daewoo Co., Ltd., Investment Arm, HisStory Investment Management, Investment arm and other investors
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A007370 Stock
  4. News Jin Yang Pharmaceutical Co., Ltd.